Fenofibrate alleviates NAFLD by enhancing the PPAR α/PGC-1α signaling pathway coupling mitochondrial function

To comprehend the influences of fenofibrate on hepatic lipid accumulation and mitochondrial function-related signaling pathways in mice with non-alcoholic fatty liver disease (NAFLD) secondary to high-fat diet...

Source: BMC Clinical Pharmacology - January 3, 2024 Category: Drugs & Pharmacology Authors: Xuemei Wang, Jieying Wang, Cao Ying, Yuan Xing, Xuan Su and Ke Men Tags: Research Source Type: research